Search Login Register

agalsidase alfa Summary

Description: genetically engineered, glycosylated human alpha-galactosidase isoenzyme A used in treatment of Fabry disease; amino acid sequence in first source

Also Known As: Replagal; TKT Europe brand of agalsidase alfa

Networked: 96 relevant articles (14 outcomes, 23 trials/studies) for this Bio-Agent

Key Diseases for which agalsidase alfa is Relevant

  1. Fabry Disease (Fabry's Disease) : 10 outcomes 20 studies in 89 results
  2. Pain (Aches) : 3 outcomes 4 studies in 12 results
  3. Neuralgia (Stump Neuralgia) : 2 outcomes 3 studies in 3 results
  4. Weight Gain : 1 outcome 1 study in 1 result
  5. Lysosomal Storage Diseases (Lysosomal Storage Disease) : 1 outcome in 2 results
Show All >>

Drugs Related to agalsidase alfa

  1. agalsidase alfa
  2. agalsidase beta
  3. globotriaosylceramide (globotriosylceramide)
  4. Creatinine
  5. imiglucerase (Cerezyme)
  6. globotriaosyl lysosphingolipid
  7. Lysergic Acid Diethylamide (LSD)
  8. Glucosidases
  9. alglucerase (Ceredase)
  10. alpha-Galactosidase (Beano)
Show All >>

Therapies Related to agalsidase alfa

  1. Enzyme Replacement Therapy
  2. Kidney Transplantation
  3. Intravenous Infusions
  4. Therapeutics
  5. Nebulizers and Vaporizers (Inhaler)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.